When will Cisatracurium Besylate Injection be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Cisatracurium Besylate Injection changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Cisatracurium Besylate Injection

Brand names: Cisatracurium Besylate

Category: Analgesia/Addiction

Not specified 3

FDA status: To Be Discontinued · Last FDA update: Sep 11, 2026 · First posted: May 6, 2026 · 1 manufacturers, 3 listed presentations

As of Sep 11, 2026, the FDA lists Cisatracurium Besylate Injection as being discontinued. Of 3 manufacturer presentations, 3 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Cisatracurium Besylate Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Cisatracurium Besylate, Injection, 10 mg/5ml (2 mg/mL) Single Dose Vial (NDC 0409-1098-02) NDC 0409-1098-02	Hospira, Inc., a Pfizer Company	Not specified	Supply expected to exhaust November 2026; Discontinuation of the manufacture of the drug
Cisatracurium Besylate, Injection, 20 mg/10 mL (2 mg/mL) Multidose Vial (NDC 0409-1208-01) NDC 0409-1208-01	Hospira, Inc., a Pfizer Company	Not specified	Supply expected to exhaust late June 2026; Discontinuation of the manufacture of the drug
Cisatracurium Besylate, Injection, 200 mg/20ml (10 mg/mL) Single Dose Vial (NDC 0409-1103-01) NDC 0409-1103-01	Hospira, Inc., a Pfizer Company	Not specified	Supply expected to exhaust late June 2026; Discontinuation of the manufacture of the drug

Related medications in shortage

Other Analgesia/Addiction medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Cisatracurium Besylate Injection (FDA data as of Sep 11, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Cisatracurium Besylate Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Cisatracurium Besylate Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/cisatracurium-besylate-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).